Skip to content
Clinical Trials – home
Region Hovedstaden
Sponsor

Region Hovedstaden

Denmark Bispebjerg Bakke 23, 2400 Herlev, Denmark

About the sponsor

Research activity includes acute heart failure, pulmonary congestion, fluid overload, and heart failure with reduced ejection fraction, alongside studies in atrial fibrillation, deep vein thrombosis, pulmonary embolism, coronary artery disease, ischemic heart disease, chronic coronary syndrome, and coronary microvascular disease.

  • Diuretic therapy and vasodilation
  • Anticoagulation and thromboembolic disease
  • Coronary inflammation and microvascular dysfunction

Additional work extends to intensive care fluid management and perioperative blood loss in surgical settings.

About Specializations

Region Hovedstaden runs clinical trials in conditions such as Infertility male, Bipolar disorder, Depression, Cardiac failure acute, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

29 clinical trials

A study to evaluate the use of leflutrozole to improve semen quality in men with non-obstructive azoospermia

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · Healthy volunteers
  • Sponsor:Region Hovedstaden

Drug dependence

Recruiting

Study of semaglutide to reduce cannabis use in adults with cannabis use disorder

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Region Hovedstaden

A Study Comparing Melatonin versus Placebo for Mood Stabilization in Patients with Bipolar Disorder

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Melatonin
  • Sponsor:Region Hovedstaden

Depression

Recruiting

Study of Flumazenil to Reduce Side Effects of Electroconvulsive Therapy in Patients with Depression

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Flumazenil
  • Sponsor:Region Hovedstaden

Diabetic foot+1

Recruiting

Study on the Effect of Semaglutide on Healing Foot Ulcers in Patients with Type 2 Diabetes

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Region Hovedstaden

Obesity+2

Recruiting

Study on the Effects of Semaglutide on Mood in Patients with Major Depressive Disorder and Overweight or Obesity

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Semaglutide
  • Sponsor:Region Hovedstaden

Study Comparing Electrochemotherapy with Bleomycin to Standard Radiotherapy for Treating Basal Cell Carcinoma in Patients with Tumors Less Than 3 cm

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bleomycin
  • Sponsor:Region Hovedstaden

Bacteraemia

Recruiting

Study on Shortened Antibiotic Treatment for Gram-negative Bacteremia in Hospitalized Adults Using Pivmecillinam Hydrochloride and Drug Combination

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Region Hovedstaden

Study Comparing Lithium and Lamotrigine for Mood Stabilization in Patients with Bipolar Disorder Type II

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Lamotrigine
  • Sponsor:Frederiksberg Hospital

Study of Metolazone and Acetazolamide Combination for Patients with Acute Heart Failure and Volume Overload

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Acetazolamide
  • Sponsor:Region Hovedstaden

Study on the Effects of Tezepelumab on Airway Inflammation in Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Region Hovedstaden

Study on Propranolol and Pembrolizumab for Patients with Advanced Angiosarcoma and Undifferentiated Pleomorphic Sarcoma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Region Hovedstaden

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.